Financial Abilities in Neurological Diseases. Development of a Telerehabilitation Program: FINAGE

NCT05826548 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2024-10-08

No results posted yet for this study

Summary

Financial Abilities (FA) are a set of capacities that allow a person to independently manage her/his financial affairs in a manner consistent with personal self-interests and values. This project will: a) assess Financial Abilities in different neurological conditions: Mild Cognitive Impairment, Parkinson's disease and Stroke patients; b) investigate both cognitive correlations, specifically the role of executive functions, thought to be critically involved in the FA multi-dimensional concept, and neuro-anatomical correlates of Financial Abilities; c) build a rehabilitation tool in order to improve FA. Secondary aims are to apply this rehabilitation tool at long distance and evaluate its behavioral, functional and neuroanatomical effects. The starting point for this project is the recently published NADL-F - Numerical Activities of Daily Living - Financial, a multi-domain ecological battery aimed at assessing FA in healthy people as well as in neurological patient populations

Conditions

Interventions

BEHAVIORAL

Telerehabilitation group

Patients will undergo the experimental intervention for 1 hour/day, for 5 days, for 4 weeks.

BEHAVIORAL

Conventioanl treatment group

Patients will undergo the control intervention for 1 hour/day, for 5 days, for 4 weeks.

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV
  • Khymeia S.r.l.

    collaborator UNKNOWN
  • Department of Neuroscience, University of Padova

    collaborator UNKNOWN
  • IRCCS San Camillo, Venezia, Italy

    lead OTHER

Principal Investigators

  • Francesca Burgio, PhD · IRCCS San Camillo Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-11
Primary Completion
2024-12-17
Completion
2025-02-17

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05826548 on ClinicalTrials.gov